A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis

Recruiting now · Phase 2 · Has a placebo group

Conditions studied: Rheumatoid Arthritis

In brief

Phase II study in participants with moderately-to-severely active rheumatoid Arthritis (RA) to evaluate efficacy and safety of AZD1163.

Key facts

Study ID
NCT07276581
Run by
AstraZeneca
People needed
320
Starts
2025-12-15
Expected to finish
2028-08-18
Last updated by the study team
2026-06-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.